
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.4B | $1.6B | $1.5B | $1.7B | $1.8B | |
Revenue Growth (YoY) | -3.76% | 7.7% | -5.85% | 17.2% | 4.66% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $151.2M | $138.2M | $125.7M | $124.9M | $138.3M | |
Other Inc / (Exp) | $54.5M | $89.2M | -$78.7M | -$39.1M | $2.5M | |
Operating Expenses | $755.8M | $820.7M | $900.2M | $634.1M | $676.6M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $423.9M | $710.4M | $450.1M | $985.5M | $1.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $97.9M | $142.5M | $114.1M | $246.6M | $248.8M | |
Net Income to Company | $325.5M | $567.9M | $336.4M | $739.4M | $822.6M | |
Minority Interest in Earnings | -$342.6K | -$118.3K | -$316.4K | -- | -- | |
Net Income to Common Excl Extra Items | $325.7M | $567.8M | $335.7M | $738.9M | $822.6M | |
Basic EPS (Cont. Ops) | $3.51 | $6.07 | $3.55 | $8.72 | $10.17 | |
Diluted EPS (Cont. Ops) | $3.46 | $6.05 | $3.54 | $8.68 | $10.09 | |
Weighted Average Basic Share | $87.9M | $88.8M | $87.2M | $81.8M | $78.5M | |
Weighted Average Diluted Share | $89.1M | $89.1M | $87.5M | $82.1M | $79.1M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $653.6M | $955.8M | $771M | $2.4B | $3B | |
Revenue (Reported) | $1.4B | $1.6B | $1.5B | $1.7B | $1.8B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $653.6M | $955.8M | $771M | $2.4B | $3B |
Period Ending | 2015-06-30 | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2019-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | $284.9M | $278.4M | $339.6M | $351.6M | |
Revenue Growth (YoY) | -- | -- | -- | 21.99% | 18.82% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | $10.3M | -$770.2K | $11.7M | $25.2M | |
Operating Expenses | -- | $142.6M | $122.7M | $152.4M | $156M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | $138.6M | $139.3M | $182.7M | $179.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $24.2M | $22.2M | $43.6M | $43M | |
Net Income to Company | -- | -- | $121.1M | $135.5M | -- | |
Minority Interest in Earnings | -- | -$113K | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $114.3M | $117.1M | $139.1M | $136.7M | |
Basic EPS (Cont. Ops) | -- | $1.14 | $1.17 | $1.40 | $1.38 | |
Diluted EPS (Cont. Ops) | -- | $1.14 | $1.17 | $1.40 | $1.38 | |
Weighted Average Basic Share | -- | $100M | $100M | $100M | $98.8M | |
Weighted Average Diluted Share | -- | $100M | $100M | $100M | $98.8M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | $221.1M | $220.9M | $284.8M | $255.9M | |
Revenue (Reported) | -- | $284.9M | $278.4M | $339.6M | $351.6M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | $221.1M | $220.9M | $284.8M | $255.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $1.5B | $1.5B | $1.7B | $1.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $151.1M | $137.3M | $124.7M | $125M | $136.9M | |
Other Inc / (Exp) | $59M | $87.2M | -$75.4M | -$38.5M | $2.7M | |
Operating Expenses | $758.3M | $815.4M | $886.4M | $634.9M | $669.5M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $427.8M | $702.2M | $450.2M | $986.1M | $1.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $98.6M | $141.4M | $114M | $246.8M | $246.3M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$330.4K | -$108.2K | -$311K | -- | -- | |
Net Income to Common Excl Extra Items | $328.8M | $560.7M | $335.9M | $739.3M | $813.8M | |
Basic EPS (Cont. Ops) | $3.54 | $5.99 | $3.56 | $8.72 | $10.07 | |
Diluted EPS (Cont. Ops) | $3.49 | $5.97 | $3.55 | $8.69 | $9.98 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | $1.5B | $1.5B | $1.5B | $1.7B | $1.8B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1B | $2.1B | $557.6M | $14.1B | $18.3B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.3B | $2.6B | $465.4M | $14.2B | $18.8B | |
Property Plant And Equipment | $407.1M | $328.3M | $287.4M | $286.3M | $264.3M | |
Long-Term Investments | $10.4B | $7.8B | $6.7B | $7.6B | $6.2B | |
Goodwill | $115.6M | $108.7M | $105.1M | $130.4M | $123.8M | |
Other Intangibles | $563.3M | $495.9M | $454.7M | $458.7M | $429.8M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $65.3B | $63.8B | $60.6B | $61.3B | $74.2B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $350.5M | $459.7M | $352.8M | $496.3M | $415.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $60B | $58.8B | $56.3B | $56.7B | $69.3B | |
Common Stock | $108.1M | $100.7M | $88.2M | $87.3M | $82.2M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $5.3B | $5B | $4.3B | $4.6B | $4.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $4.9M | $5.7M | -- | -- | -- | |
Total Equity | $5.4B | $5B | $4.3B | $4.6B | $4.9B | |
Total Liabilities and Equity | $65.3B | $63.8B | $60.6B | $61.3B | $74.2B | |
Cash and Short Terms | $1.1B | $2.1B | $557.6M | $14.1B | $18.3B | |
Total Debt | $8.2B | $8.6B | $11.2B | $15.4B | $18.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1B | $2.1B | $557.6M | $14.1B | $18.3B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.3B | $2.6B | $465.4M | $14.2B | $18.8B | |
Property Plant And Equipment | $407.1M | $328.3M | $287.4M | $286.3M | $264.3M | |
Long-Term Investments | $10.4B | $7.8B | $6.7B | $7.6B | $6.2B | |
Goodwill | $115.6M | $108.7M | $105.1M | $130.4M | $123.8M | |
Other Intangibles | $563.3M | $495.9M | $454.7M | $458.7M | $429.8M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $65.3B | $63.8B | $60.6B | $61.3B | $74.2B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $350.5M | $459.7M | $352.8M | $496.3M | $415.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $60B | $58.8B | $56.3B | $56.7B | $69.3B | |
Common Stock | $108.1M | $100.7M | $88.2M | $87.3M | $82.2M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $4.9M | $5.7M | -- | -- | -- | |
Total Equity | $5.4B | $5B | $4.3B | $4.6B | $4.9B | |
Total Liabilities and Equity | $65.3B | $63.8B | $60.6B | $61.3B | $74.2B | |
Cash and Short Terms | $1.1B | $2.1B | $557.6M | $14.1B | $18.3B | |
Total Debt | $8.2B | $8.6B | $11.2B | $15.4B | $18.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $325.5M | $567.9M | $336.4M | $739.4M | $822.6M | |
Depreciation & Amoritzation | $71.7M | $81M | $66.2M | $170M | $148.3M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.7B | $369.2M | -$368.1M | $1.4B | $1.3B | |
Capital Expenditures | $24M | $49.7M | $60.1M | $34.6M | $55.2M | |
Cash Acquisitions | -$12.6M | -$369.2M | -$4.2M | -$3.2M | $2.1B | |
Cash From Investing | -$2.5B | $1.4B | -$398.6M | -$509.9M | $4.2B | |
Dividends Paid (Ex Special Dividend) | -- | -$544.3M | -$281.6M | -$330.2M | -$425.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $228.4M | -- | -- | $432M | -- | |
Long-Term Debt Repaid | -$51.4M | -$3.5M | -- | -$459M | -$112.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $182.7M | -$29.6M | -$26.4M | -$26M | $233.8M | |
Cash From Financing | $328.9M | -$607M | -$682.3M | -$606.3M | -$335.5M | |
Beginning Cash (CF) | $1.5B | $1.1B | $2B | $13.5B | $13.8B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$475.1M | $1.2B | -$1.4B | $293.4M | $5.2B | |
Ending Cash (CF) | $1B | $2.2B | $548.4M | $13.8B | $19.1B | |
Levered Free Cash Flow | $1.6B | $319.5M | -$428.2M | $1.4B | $1.3B |
Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | $155.8M | $135.8M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | $1B | $329.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -$545.9M | -$1.1M | |
Cash From Investing | -- | -- | -- | -$487M | $81.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | $2.2M | -$1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $16.5M | $454M | |
Cash From Financing | -- | -- | -- | $13M | -$43.5M | |
Beginning Cash (CF) | -- | -- | -- | $842.9M | $873.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $537.4M | $367.8M | |
Ending Cash (CF) | -- | -- | -- | $1.3B | $1.3B | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.